Brief: Trevi Therapeutics Says Lisa Delfini To Resign As CFO On Aug 22
20/08/2025 21:44
Aug 20 (Reuters) - Trevi Therapeutics Inc TRVI.O: TREVI THERAPEUTICS INC - LISA DELFINI TO RESIGN AS CFO OF TREVI THERAPEUTICS ON AUG 22 - SEC FILING TREVI THERAPEUTICS INC - JENNIFER L. GOOD TO SERVE AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING Source text: [ID:n0001563880-25-000005] Further company coverage: TRVI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Trevi Therapeutics
See all newsTrevi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Trevi Therapeutics Q2 net loss widens on higher R&D costs
Brief: Trevi Therapeutics Q2 Net Income USD -17.797 Million
Trevi Therapeutics Q1 net loss widens as R&D costs rise
Brief: Trevi Therapeutics Q1 Net Income USD -13.192 Million